Cargando…
Performance of Elecsys Anti-SARS CoV-2 (Roche) and VIDAS Anti-SARS CoV-2 (Biomérieux) for SARS-CoV-2 Nucleocapsid and Spike Protein Antibody Detection
INTRODUCTION: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the novel viral pathogen that causes coronavirus disease 2019 (COVID-19) in humans, has spread worldwide since its identification in late 2019. The pandemic produced an accelerated development of new serological techniques f...
Autores principales: | Inés, Riberi María, Gabriela, Hernandez Toledo Marina, Paula, Cid Mariana, Magdalena, Tenaglia María, Jimena, Alfaro, Salome, Konigheim Brenda, Javier, Aguilar Juan, Sebastián, Blanco, Lorena, Spinsanti, Adrián, Díaz Luis, Elisa, Rivarola, Mauricio, Beranek, Tersita, Bottiglieri Marina, Verónica, Gallego Sandra, Beatriz, Isa María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562483/ https://www.ncbi.nlm.nih.gov/pubmed/36313907 |
Ejemplares similares
-
Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay
por: Riester, Elena, et al.
Publicado: (2021) -
Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay
por: Taffertshofer, Karin, et al.
Publicado: (2022) -
Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2
por: Riester, Elena, et al.
Publicado: (2021) -
Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
por: Ben Abdelhanin, Myriam, et al.
Publicado: (2021) -
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
por: Muench, Peter, et al.
Publicado: (2020)